Ki-Hong Sung

Title: Innovations of Ki-Hong Sung

Introduction

Ki-Hong Sung is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of novel solutions for bacterial infections and viral diseases. With a total of two patents to his name, Sung's work is recognized for its potential impact on public health and aquaculture.

Latest Patents

Sung's latest patents include a bacteriophage and its use for preventing the proliferation of pathogenic bacteria. This invention relates to a novel phage that has been newly isolated and identified. The composition aims to inhibit the growth of bacteria or kill them, making it applicable for preventing or treating bacterial infectious diseases, treating ballast water, and serving as an antibiotic or antiseptic. His second patent focuses on a composition and method for treating or preventing white spot syndrome virus in arthropods. This invention utilizes a mixture of extracts as an effective agent, providing a method for addressing this viral threat in aquatic species.

Career Highlights

Ki-Hong Sung is associated with CTC Bio, Inc., where he continues to innovate and develop solutions in biotechnology. His work is characterized by a commitment to addressing critical health challenges through scientific research and development.

Collaborations

Sung collaborates with notable colleagues, including Dae-Keon Choi and Jae-Hoon Kim, who contribute to his research endeavors and enhance the impact of his inventions.

Conclusion

Ki-Hong Sung's contributions to biotechnology through his patents demonstrate his dedication to advancing health solutions. His innovative work in bacteriophage technology and viral treatment showcases the potential for significant advancements in public health and aquaculture.